4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid

C20H22F2N8O4 — CID 66839544

IUPAC4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid
SMILESO=C(O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4c(O)cccc43)n2)CC1
InChIInChI=1S/C20H22F2N8O4/c21-15(22)16-23-14-12(2-1-3-13(14)31)30(16)19-25-17(27-4-6-29(7-5-27)20(32)33)24-18(26-19)28-8-10-34-11-9-28/h1-3,15,31H,4-11H2,(H,32,33)
InChIKeyBRSZZOBKZQIZIP-UHFFFAOYSA-N
MW476.44 g/mol
LogP1.49
Rot. Bonds4

About 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid

4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid (PubChem CID 66839544) has the molecular formula C20H22F2N8O4 and a molecular weight of 476.44 g/mol. Its IUPAC name is 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid.

Molecular Properties

Compound Name4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid
PubChem CID66839544
Molecular FormulaC20H22F2N8O4
Molecular Weight476.44 g/mol
Exact Mass476.17
IUPAC Name4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid
SMILESO=C(O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4c(O)cccc43)n2)CC1
InChIInChI=1S/C20H22F2N8O4/c21-15(22)16-23-14-12(2-1-3-13(14)31)30(16)19-25-17(27-4-6-29(7-5-27)20(32)33)24-18(26-19)28-8-10-34-11-9-28/h1-3,15,31H,4-11H2,(H,32,33)
InChIKeyBRSZZOBKZQIZIP-UHFFFAOYSA-N
XLogP1.49
TPSA132.97 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds4
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500476.44
LogP ≤ 51.49
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid?
The IUPAC name of 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid (CID 66839544) is 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid.
What is the SMILES notation for 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid?
The canonical SMILES for 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid is O=C(O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4c(O)cccc43)n2)CC1.
What is the InChIKey of 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid?
The InChIKey is BRSZZOBKZQIZIP-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H22F2N8O4/c21-15(22)16-23-14-12(2-1-3-13(14)31)30(16)19-25-17(27-4-6-29(7-5-27)20(32)33)24-18(26-19)28-8-10-34-11-9-28/h1-3,15,31H,4-11H2,(H,32,33).
What are the key properties of 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid?
4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid has a molecular weight of 476.44 g/mol, XLogP of 1.49, 4 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[2-(difluoromethyl)-4-hydroxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylic acid is sourced from PubChem (CID 66839544), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).